These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 29575236)
1. DMC is not better than TMZ on intracranial anti-glioma effects. Shi L; Sun G J Cell Biochem; 2018 Jul; 119(7):6057-6064. PubMed ID: 29575236 [TBL] [Abstract][Full Text] [Related]
2. Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas. Shi L; Sun G; Zhang Y Aging (Albany NY); 2020 Nov; 12(23):23795-23807. PubMed ID: 33221748 [TBL] [Abstract][Full Text] [Related]
3. Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro. Shi L; Sun G Neuromolecular Med; 2015 Dec; 17(4):431-42. PubMed ID: 26458914 [TBL] [Abstract][Full Text] [Related]
4. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
5. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy. Mao J; Meng X; Zhao C; Yang Y; Liu G Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310 [TBL] [Abstract][Full Text] [Related]
6. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related]
7. Andrographolide sensitizes glioma to temozolomide by inhibiting DKK1 expression. Zhang ZS; Gao ZX; He JJ; Ma C; Tao HT; Zhu FY; Cheng YN; Xie CQ; Li JQ; Liu ZZ; Hou LL; Sun H; Xie SQ; Fang D Br J Cancer; 2024 Nov; 131(8):1387-1398. PubMed ID: 39266624 [TBL] [Abstract][Full Text] [Related]
8. Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells. Shi L; Fei X; Wang Z Tumour Biol; 2015 Sep; 36(9):7107-19. PubMed ID: 25877753 [TBL] [Abstract][Full Text] [Related]
9. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction. Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385 [TBL] [Abstract][Full Text] [Related]
10. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway. Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676 [TBL] [Abstract][Full Text] [Related]
12. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth. Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126 [TBL] [Abstract][Full Text] [Related]
13. Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo. Leng L; Zhong X; Sun G; Qiu W; Shi L Tumour Biol; 2016 Oct; ():. PubMed ID: 27757851 [TBL] [Abstract][Full Text] [Related]
14. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition. Liu T; Li A; Xu Y; Xin Y Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175 [TBL] [Abstract][Full Text] [Related]
15. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978 [TBL] [Abstract][Full Text] [Related]
16. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057 [TBL] [Abstract][Full Text] [Related]
17. Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo. Bai Y; Chen Y; Hong X; Liu X; Su X; Li S; Dong X; Zhao G; Li Y Sci Rep; 2018 Jul; 8(1):11470. PubMed ID: 30065314 [TBL] [Abstract][Full Text] [Related]
18. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456 [TBL] [Abstract][Full Text] [Related]
19. Juniperus Communis Extract Exerts Antitumor Effects in Human Glioblastomas Through Blood-Brain Barrier. ; Tsai NM; Chang KF; Wang JC Cell Physiol Biochem; 2018; 49(6):2443-2462. PubMed ID: 30261501 [TBL] [Abstract][Full Text] [Related]
20. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]